w

Durbin Expanded Access Program Resources Center

As Expanded Access Program (EAP) experts, we keep our finger on the pulse of a fast-moving environment. We have created this space as a touchstone through which you can keep up to date with the very latest expanded access activity and insights.

Durbin Expanded Access Program Resources Center

As Expanded Access Program (EAP) experts, we keep our finger on the pulse of a fast-moving environment. We have created this space as a touchstone through which you can keep up to date with the very latest expanded access activity and insights.

w
Evaluating the cost impact of an Expanded Access Program

Evaluating the Cost Impact of an Expanded Access Program

The ultimate goal of an EAP is to provide much-needed treatment to patients who have an urgent need, but companies must find balance in managing program costs.
Image

Zogenix Launches Global Access Program for FINTEPLA® (Fenfluramine) Oral Solution

Image

New Partnership Announcement

Uniphar has been appointed to design and implement a global Managed Access Program (MAP) for the product range of Secura Bio, Inc. (“Secura Bio”) through its subsidiary, Durbin plc (“Durbin”).
RWD collection in expanded access programs

Implementing Real World Data Collection in Expanded Access Programs (EAPs)

Building Real-World Data collection initiatives into an EAP design can offer apparent benefits. What are some of the considerations and practical implementation solutions for RWD collection in expanded access?
Optimizing commercial launch for orphan drugs

Optimizing Commercial Launch for Orphan Drugs With Expanded Access Programs

There are between 25 and 30 million people in the U.S. alone living with rare conditions. EAPs can be instrumental in both ensuring patient access to treatment, and as a key step on the path to commercialization
The EAP playbook

The Expanded Access Program (EAP) Playbook

When considering running an expanded access program (EAP), drug manufacturers typically find themselves at a crossroad, weighing up the benefits of delivery against the obstacles that might be in the way.  
Image

COVID-19 Is No Obstacle to Expanded Access

COVID-19 is no obstacle to expanded accessCOVID-19 is no obstacle to expanded access
Doctors

Global Early Access Program for New Medicine

Durbin appointed by Jazz Pharmaceuticals to Coordinate Global Early Access Program for New Medicine